Chlorodehydromethyltestosterone

Chlorodehydromethyltestosterone (CDMT; brand name Oral Turinabol), also known as 4-chloro-17β-hydroxy-17α-methylandrosta-1,4-dien-3-one, is an anabolic steroid that is derived from testosterone. This synthetic steroid has a similar structure to methandrostenolone, but with the added 4-chloro alteration of clostebol.

History

Chlorodehydromethyltestosterone was first described in 1962 and was introduced for medical use by Jenapharm, an East German pharmaceutical company. The primary goal of this drug was to help East German athletes to improve their performance in sports, which was a common practice at the time, known as doping.

Medical Use

Chlorodehydromethyltestosterone has been used as a treatment for various medical conditions. It was prescribed for use in cases of muscle wasting and recovery from surgical procedures. However, it is no longer used medically and is not available as a prescription medication in most countries.

Side Effects

Like other anabolic steroids, chlorodehydromethyltestosterone can have significant side effects. These can include liver damage, cardiovascular disease, and effects on mood and behavior. It can also cause virilization in women and children, leading to features such as a deepened voice, increased body hair, and an enlarged clitoris.

Legal Status

In many countries, including the United States, chlorodehydromethyltestosterone is classified as a controlled substance. It is also on the World Anti-Doping Agency's list of prohibited substances, and athletes testing positive for it can face disciplinary action.

See Also

• Anabolic steroid
• Doping in sports
• Testosterone

References

<references />

This article is a stub related to pharmacology. You can help WikiMD by expanding it!

• 
  Chlorodehydromethyltestosterone